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The yeast URA2 gene, encoding the rate-limiting enzyme
of UTP biosynthesis, is transcriptionally activated by UTP
shortage. In contrast to other genes of the UTP pathway,
this activation is not governed by the Ppr1 activator.
Moreover, it is not due to an increased recruitment of
RNA polymerase II at the URA2 promoter, but to its
much more effective progression beyond the URA2
mRNA start site(s). Regulatory mutants constitutively ex-
pressing URA2 resulted from cis-acting deletions upstream
of the transcription initiator region, or from amino-acid
replacements altering the RNA polymerase II Switch 1
loop domain, such as rpb1-L1397S. These two mutation
classes allowed RNA polymerase to progress downstream
of the URA2 mRNA start site(s). rpb1-L1397S had similar
effects on IMD2 (IMP dehydrogenase) and URA8 (CTP
synthase), and thus speciﬁcally activated the rate-limiting
steps of UTP, GTP and CTP biosynthesis. These data
suggest that the Switch 1 loop of RNA polymerase II,
located at the downstream end of the transcription bubble,
may operate as a speciﬁc sensor of the nucleoside tripho-
sphates available for transcription.
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Introduction
DNA transcription depends on the availability of pyrimidine
(UTP and CTP) and purine (GTP and ATP) ribonucleoside
triphosphate substrates, and their de novo synthesis is sub-
jected to tight homoeostatic controls. In yeast, the ﬁrst two
steps of UTP biosynthesis are catalysed by Ura2, a bifunc-
tional protein endowed with carbamoyl phosphate synthetase
and aspartate transcarbamoylase activities (Potier et al,
1987). These are the main rate-limiting steps of the pathway,
and their allosteric control by UTP is well documented
(Lacroute et al, 1965; Serre et al, 2004). Similar to other
genes of the UTP biosynthetic pathway, URA2 transcription is
induced in the presence of 6-azauracil, which depletes cells in
UTP (Exinger and Lacroute, 1992). A previous study (Losson
and Lacroute, 1981) has suggested that this does not depend
on Ppr1, a transcriptional activator speciﬁc for the pyrimidine
biosynthetic pathway (Loison et al, 1980; Losson and
Lacroute, 1981; Flynn and Reece, 1999), as ppr1-2, a mutation
unable to activate URA1 or URA3, had no effect on
Ura2 activity in cell-free extracts. Moreover, we here show
that a ppr1D null allele remains fully competent for URA2
transcription.
In this study, two classes of mutations were found to
constitutively activate pURA2HHIS3 or pURA2HLacZ repor-
ter plasmids. The ﬁrst class was due to short deletions
immediately upstream of the URA2 mRNA 50-ends, indicating
that this region acts as negative regulatory element of URA2
transcription. A second class altered RPB1, which encodes the
largest subunit of RNA polymerase II, and speciﬁcally mod-
iﬁed the Switch 1 loop of the active site. One of these
mutations, rpb1-L1397S, was investigated in more detail. It
showed a genome-wide reduced occupancy of RNA polymer-
ase II, consistent with its partial growth defect, but speciﬁ-
cally activated URA2, IMD2/IMD3 and URA8 (encoding
rate-limiting steps of the UTP, GTP and CTP biosynthetic
pathways, respectively), thus raising the intriguing possibility
that the Switch 1 loop of RNA polymerase II might act as a
sensor of nucleoside triphosphate depletion.
Results
UTP depletion activates URA2 independently
of the Ppr1 activator
The URA2 open reading frame is separated by 1231nt from
the stop codon of the upstream gene TRK1 (Figure 1A). A
KpnI–BamHI cassette bearing this DNA was cloned in frame
with the LacZ or HIS3 open reading frames, generating the
pURA2HLacZ reporter plasmids pFL80 and pFL80-H2, and
the pURA2HHIS3 reporter pFL81 (Materials and methods).
There was a ﬁvefold LacZ activation in wild-type cells grown
under repressing (uracil) or derepressing (6-azauracil) con-
ditions (Figure 1B), and a similar range of activation was
observed in the steady-state level of URA2 mRNAs
(Figure 1C), indicating that the pURA2HLacZ reporter cor-
rectly reﬂects the transcriptional regulation of URA2.
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2411Adding 6-azauracil blocks UTP synthesis and also
reduces the cellular pool of GTP (Exinger and Lacroute,
1992). However, no pURA2HLacZ activation was observed
in the presence of mycophenolate, which speciﬁcally
blocks IMP dehydrogenase (Shaw et al, 2001), and thus
only depletes GTP. Likewise, counteracting GTP inhibition
by adding guanine to the CSMþ6AU medium did not
reduce the activating effect of 6-azauracil (data not shown).
Finally, impairing the metabolic conversion of UTP to
CTP in temperature-sensitive mutant (ura8-ts ura7D)
reduced the expression of pURA2HLacZ, which presumably
reﬂects the accumulation of UTP under these conditions
and implies that URA2 does not respond to CTP shortage.
These data indicated that URA2 transcription is primarily
activated by a shortage in UTP, with little or no effect of GTP
or CTP.
Other genes of the pyrimidine pathway, such as URA1
and URA3, are also derepressed under UTP depletion, and
their activation is lost in ppr1-2, a mutation that alters the
Ppr1 activator but has no effect on the Ura2 activity in cell-
free extracts (Losson and Lacroute, 1981). Consistent with
this observation, we found here that the ppr1D null allele
strongly reduced the activation of URA1 and URA3 in the
presence of 6-azauracil, as measured by RT–PCR quantiﬁca-
tion of their mRNAs and by their RNA polymerase II occu-
pancy in chromatin-immunoprecipitation (ChIP) assays
(shown in Figure 1C for the URA1 gene). In contrast, ppr1D
actually increased the level of URA2 mRNA produced in the
presence of 6-azauracil, which may reﬂect a particularly
effective depletion in UTP, due to its inability to activate
URA1 and URA3.
Organisation of the URA2 promoter region
It was previously thought that URA2 transcription starts some
70nt ahead of the ATG start codon (Potier et al, 1990). This is
clearly inconsistent with the recent report of an untranslated
intron between positions  385 and  66 relatively to the ATG
(Juneau et al, 2007). As shown in Figure 2, we conﬁrmed the
existence of this intron, although with different 30-ends
corresponding to positions  63,  54 or, in one case, þ12.
The corresponding DNA has a 50-end consensus
( 384GUAUGU 379), a canonical branch point box
( 92UACUAAC 84), and a  68UAG 65 at the 30-splice site. An
intron deletion did not detectably affect the expression of
pURA2HLacZ (bottom line of Figure 2A).
Using RNA ligase mediated-RACE assays, we obtained and
sequenced 13 cDNAs that, by construction, extended to
position þ188 of the URA2 open reading frame and thus
corresponded to the 50-end domains of full-length mRNAs
(Figure 2B). These 50-ends deﬁned six positions ( 588A,
 579T,  576A,  571A,  565A and  563A) clustered within
an A-rich domain, matching to the initiator consensus
(Arich)5N(C/T)A(A/T)NN(Arich)6 deduced from a recent sur-
vey of yeast mRNAs (Zhang and Dietrich, 2005). A parallel
study (Thiebaut et al, 2008) has identiﬁed a second initiator
region (positions  686/ 657, denoted by a grey arrow in
Figure 2A) upstream of the one shown here to be used for
full-length URA2 mRNAs. This upstream initiator produces
short unstable non-coding RNAs with the same transcrip-
tional orientation as URA2. It is evidently not used to produce
full-length URA2 transcripts, as the predicted 50-ends were
not found in the corresponding cDNAs (Figure 2B). Five
TCTT (UCUU) boxes, present immediately upstream of the
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Figure 1 Transcriptional regulation of URA2 in response to UTP shortage. (A) Schematic view of the TRK1–URA2 intergenic region. The
corresponding DNAwas cloned as a KpnI–BamHI cassette to generate the pFL80 and pFL80-H2 pURA2HLacZ reporter plasmids. A box denotes
the 50-UTR intron. The broken arrow corresponds to the URA2 mRNAs 50-ends. (B) b-galactosidase activities of BMA64-URA3 (WT) and FL55
(ura8-ts ura7D) grown without uracil (CSM) at 30 and 341C, in the presence of uracil (CSMþU), mycophenolate (CSMþMPA) and 6-azauracil
(CSMþ6AU). (C) Three independent cultures of BMA64-URA3 (WT) and FL53 (ppr1D) were exponentially grown without ( URA) or with
uracil (þURA), or with 200mg/l of 6-azauracil (þ6AU). URA1 and URA2 mRNAs were quantiﬁed by RT–PCR, and RNA polymerase II
occupancy was determined by ChIP assays, using anti-CTD antibodies (8WG16). A schematic map represents the URA1 gene, with the
oligonucleotide pairs used as primers. Position 1 corresponds to the start codon.
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Nab3, which belongs to the transcriptional terminator system
operating on non-coding intergenic RNAs (Arigo et al, 2006;
Thiebaut et al, 2006).
The DNA upstream of the URA2 initiator prevents
the progression of RNA polymerase II
Partial deletions of the TRK1-URA2 intergenic region
were introduced in pURA2HLacZ reporters (pFL80
and pFL80-H2) and tested for LacZ activation under
repressing (uracil) and derepressing (6-azauracil) conditions.
Deleting the ﬁrst 297nt had no effect on pURA2HLacZ,
but a BsrGI/SalI deletion lacking positions  934/ 580
almost entirely blocked pURA2HLacZ expression
(Figure 2A). The corresponding DNA is therefore critical for
URA2 transcription. It contains a TATAAA box ( 776/ 771)
shown by Thiebaut et al (2008) to be needed for the synthesis
of the URA2 mRNA and of its short-lived upstream tran-
scripts.
The BsrGI/SalI DNA was submitted to error-prone ampli-
ﬁcation and recombined into the pURA2HHIS3 reporter
(pFL83), producing plasmids that were selected for HIS3
overexpression in the presence of uracil. No single-base
mutation was isolated by this approach, but we obtained
three very similar deletions up2D ( 647/ 577), up6D
( 634/ 579) or up10D ( 650/ 579) upstream of the SalI
site (Figure 3A). These deletions overexpressed LacZ when
subcloned into pURA2HLacZ reporters (pFL80-H2 and
pFL80), and a chromosomal up2D mutant (FL51) constitu-
tively expressed the URA2 mRNA under-repressing condi-
tions (Figure 3B). Moreover, up2D only acted in cis, as the
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Figure 2 Organisation of the URA2 promoter region. (A) Deletion mutagenesis of promoter region. LacZ expression in BMA64-URA3 (WT)
transformed with pFL80 (pURA2HLacZ), pFL80-KBD (KpnI–BsrGI deletion), pFL80-BSD (BsrGI–SalI deletion) and pFL80-INTD (no intron).
Strains were exponentially grown without ( URA) or with uracil (þURA), or with 200mg/l of 6-azauracil (þ6AU). b-galactosidase was
expressed in arbitrary units (Miller, 1972), where 1.0 is the level measured in wild-type cells grown in CSM. Broken arrows correspond to the
transcriptional initiator regions, shown in black for full-length URA2 mRNA and in grey for short upstream untranslated RNAs (Thiebaut et al,
2008). A canonical TATAAA box and a cluster of TCTT (UCUU) motifs (stars) are also indicated (see Supplementary data). (B) Identiﬁcation of
the URA2 50-end region and of an URA2 intron. Thirteen cDNAs primed from an oligonucleotide corresponding to positions 167/188 of the
URA2 open reading frame were ampliﬁed by the RNA Ligase Mediated-RACE technique (Materials and methods). The six URA2 start sites
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M9 (rpb1-L1397S) grown without uracil ( URA). This also conﬁrmed the existence of an intron between positions  385 and  66 (Juneau et al,
2007), but with 30-borders corresponding to positions  63,  54 or, in one case, þ12.
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Figure 3 The DNA upstream of the transcription start impairs
URA2 expression. (A) Schematic organisation of the upD mutations.
Thick black line corresponds to the deleted DNA up2D, up6D and
up10D. Stars indicate TCTT (UCUU) boxes. Broken arrows corre-
spond to the transcriptional initiator regions as shown in Figure 2A.
(B) Effect of up2D on pURA2HLacZ expression and URA2 mRNA
steady-state level. BMA64-URA3 (WT) was transformed with pFL80
or pFL80-up2D. b-galactosidase was tested as shown in Figure 2A.
URA2 mRNA is expressed in arbitrary units (Miller, 1972), where
1.0 corresponds to wild-type cells grown in the absence of uracil
( URA). RT–PCR assays are based on three independent cultures of
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without uracil ( URA), or containing 200mg/l of 6-azauracil
(þ6AU).
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up2D host (data not shown).
The ChIP assays of Figure 4A show that the region up-
stream of the URA2 start site is occupied by TFIIB and TFIIH,
two components of the RNA polymerase II pre-initiation
complex. The corresponding RNA polymerase II signal was
recognised by anti-CTD antibodies, and also by an anti-
Rpb3HHA tag (see Figure 7D below), but not by antibodies
raised against Ser2-phosphorylated CTD (Figure 4B). The
CTD-Ser2
P signal was only detected downstream of the
URA2 initiator region. As shown in Figure 4C, this also
coincided with a drop in RNA polymerase II occupancy,
observed in wild-type or ppr1D cells grown under repressing
conditions.
URA2 activation in wild-type or ppr1D cells exposed to 6-
azauracil did not increase the RNA polymerase II signal
detected upstream of the initiator region, but correlated
with a full occupancy of the URA2 open reading frame by
RNA polymerase II (Figure 4C). Likewise, the up2D mutation
produced a strong RNA polymerase II signal downstream of
the initiator, even when grown under repressive conditions
(Figure 4C). Thus, URA2 activation is not due to an increased
recruitment of RNA polymerase II (as in the case of Ppr1-
dependent genes such as URA1; see Figure 1C) but results
from an extended RNA polymerase II occupancy downstream
of the URA2 initiator region. Moreover, a relatively short DNA
region, lost in up2D and located immediately upstream of the
URA2 initiator, impairs URA2 transcription by preventing
RNA polymerase II from progressing towards the URA2
open reading frame.
Mutants of the RNA polymerase II Switch 1 loop
activate URA2 expression
To search for trans-acting regulator(s) of URA2, mutations
constitutively expressing the chromosomal pURA2HHIS3 re-
porter of strain FL52 were selected after UV mutagenesis. We
obtained four mutants (FL-M9, M10, M13 and M23) that were
resistant to 3-aminotriazol on uracil-supplemented medium
and also overexpressed the pURA2HLacZ reporter. They grew
slowly at 301C, failed to grow at 161C and 371C and were
somewhat sensitive to 6-azauracil (shown in Figure 5A for
the FL-M9 strain). Meiotic tetrad analysis showed that these
phenotypes co-segregated in a monogenic and recessive way,
and complementation tests established that the correspond-
ing mutations belonged to one and the same gene.
We then transformed FL-M9 with a yeast genomic library
and obtained one plasmid restoring growth at 371C. The
corresponding insert harboured RPB1, which encodes the
largest subunit of RNA polymerase II, and three surrounding
genes. Further subcloning showed that growth at 371C
correlated with an intact RPB1 gene, and complementation
tests with the temperature-sensitive allele rpb1-1 (Scafe et al,
1990) ﬁrmly established that all four mutants were due to
rpb1 mutations. In vivo gap repair (Rothstein, 1991) indicated
that these mutations belonged to the SwaI–PshAI segment of
RPB1. Finally, DNA sequencing revealed single amino-acid
replacements corresponding to rpb1-L1397S (M9), rpb1-
S1401P (M10) and rpb1-F1402L (M13 and M23), which
were also present in the chromosomal DNA of the original
mutant strains.
The above-mentioned data led to the rather unexpected
conclusion that URA2 activation occurs by trans-acting muta-
tions altering RNA polymerase II itself, at the level of its
Switch 1 loop fold. RT–PCR and LacZ assays conﬁrmed that
+6AU +URA +6AU +URA +6AU +URA
TRK1 URA2
5913/6068
4865/5009
3744/3892
2790/2942
1870/2023
895/1042
–257/–105
–584/–432
–722/–564
–894/–744
–1395/–1259
–1864/–1714
–894/–744
–1395/–1259
–894/–744
–722/–564
–584/–432
–257/–105
895/1042
–722/–564
–584/–432
–257/–105
–895/1042
2790/2942
4865/5009
0
5
10
15
20
25
30
35
F
o
l
d
 
e
n
r
i
c
h
m
e
n
t
F
o
l
d
 
e
n
r
i
c
h
m
e
n
t
WT ppr1Δ up2Δ
RNA polymerase II (CTD) on URA2
RNA polymerase II (CTD) on URA2
URA2 (6645 bp)
5
10
15
20 70
60
50
40
30
20
10
CTD CTD-Ser5
P CTD-Ser2P
URA2
TATAAA TRK1
TFIIH
TFIIB
O
c
c
u
p
a
n
c
y
Figure 4 Distribution of TFIIB, TFIIH and RNA polymerase II at the
URA2 locus. (A) TFIIH (Rad3-TAP) and TFIIB (Sua7-TAP) were
detected by ChIP assays as described in Materials and methods.
Strains D712-10C (WT RAD3HTAP) and D714-5D (WT SUA7HTAP)
were grown on SDþaa. The schematic organisation of the corre-
sponding DNA is presented below. Broken arrows represent the
URA2 mRNA start sites and the upstream initiator, as in Figure 2A.
(B) RNA polymerase II was immunoprecipitated with Dynabeads
anti-mouse (Dynal Biotech), using anti-CTD (8WG16), anti-Ser2
P
and anti-Ser5
P antibodies (Covance). Strain GR44-11C (WT) was
grown on SDþaa. A schematic map indicates the oligonucleotides
used as primers. (C) RNA polymerase II occupancy in wild-type,
ppr1D and up2D. Strains GR44-11C (WT), FL53 (ppr1D) and FL51
(up2D) were grown at 301Co nS Dþaa with 2g/l of uracil (þURA)
or exposed to 200mg/l of 6-azauracil (þ6AU). ChIP signals were
detected with anti-CTD antibodies (8WG16). A schematic map
represents the URA2 gene, with the oligonucleotides used as
primers.
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Moreover, an rpb1-L1397S up2D double-mutant had the
same constitutive expression as up2D alone, and a
pURA2HLacZ reporter bearing the up2D allele (plasmid
pFL80-up2D) was expressed at the same level when tested
in wild-type or in an rpb1-L1397S host strain (Figure 5B and
C). In other words, rpb1-L1397S and up2D have epistatic
effects on URA2 expression, thus strongly suggesting that
they are defective in the same mechanism downregulating
URA2 in response to uracil.
The six amino-acid segment occupied by L1397, S1401 and
F1402 corresponds to Rpb1-a47b, one of the two a helices
forming the Switch 1 loop domain of the RNA polymerase II
active site (Gnatt et al, 2001). Moreover, the rpb1-G1388V
allele, altering the Rpb1-a47a helix (Berroteran et al, 1994),
also resulted in a high constitutive expression of URA2 (data
not shown). This high clustering was not anticipated in a UV
mutagenesis, as the latter evidently affects the whole yeast
genome. Our genetic screen was presumably not saturating,
and we cannot exclude that URA2 activation may, for some
reason, be a general property of partly defective RNA poly-
merase II mutants. We thus tested the pURA2HLacZ reporter
(pFL80) in 10 other slow-growing mutations partly impairing
Rpb1 (rpb1-G1437D, rpb1-E1351K and rpb1-H1367D) or Rpb2
(rpb2-R857K, rpb2-E836A, rpb2-D978A, rpb2-P1018S and
rpb2-G1142D) or lacking the non-essential subunits Rpb4
(rpb4D) or Rpb9 (rpb9D) (Woychik and Young, 1989; Scafe
et al, 1990; Woychik et al, 1991). Except for a modest
derepressing effect of rpb2-E836A and rpb2-R857K, their b-
galactosidase activity was equal to or lower than the wild-
type control (data not shown), thus strongly suggesting that
URA2 activation, at least to a large extent, is primarily due to
changes in the Switch 1 loop.
The Switch1 loop is highly conserved in all eukaryotic and
archaeal RNA polymerases (Figure 6A). Together with the
a25 Bridge helix, a36 Trigger helix and the a46/47 Loop of
Rpb1, it forms an identical fold in the RNA polymerase of
Sulfolobus solfataricus (Hirata et al, 2008) and in yeast RNA
polymerase II (Gnatt et al, 2001). This fold wraps the down-
stream end of the transcription bubble and holds the DNA
template strand by the invariant R1386-E1403 Switch 1 dipole
(Figure 6B and C). As discussed elsewhere (Zaros et al, 2007),
this fold is stabilised by the C-end of the Rpb5 subunit, itself
strongly conserved from archaea to eukaryotes. Bacterial
RNA polymerases, on the other hand, have no Rpb5 and
their Switch 1 loop is considerably extended but nevertheless
adopts a very similar spatial orientation (Vassylyev et al,
2007).
rpb1-L1397S enhances RNA polymerase II occupancy
downstream of the URA2 initiator
Consistent with the partial growth defects of rpb1-L1397S,a
twofold reduction in RNA polymerase II occupancy was seen
for rpb1-L1397S in single-gene ChIP assays at ADH1 or PYK1
(Figure 7A). This extended to the whole genome, with an
average occupancy level of 62% (R
2¼0.80) relatively to wild
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supplemented with mycophenolate (50mg/l) or 6-azauracil (20 and 200mg/l). FL53 (ppr1D) and FL51 (up2D) were used as controls. Cells
were microphotographed in exponential cultures grown in SDþaa at 301C. (B) Expression of pURA2HLacZ. b-galactosidase was assayed as
shown in Figure 2A, in strains BMA64-URA3 (WT) and FL-M9-URA3 (rpb1-L1397S) transformed with the pFL80 or pFL80-up2D pURA2HLacZ
reporter plasmids. (C) GR44-11C (WT) or YGH2 (WT), D711-13B (rpb1-L1397S), FL51 (up2D) and D876-10D (rpb1-L1397S up2D) were
exponentially grown in CSM. Total RNA was extracted as described in Materials and methods. Steady-state levels of URA1, URA2 and URA3
mRNAs were quantiﬁed by RT–PCR and expressed in arbitrary units, where 1.0 corresponds to the wild-type level of URA1 mRNA in CSM
medium for URA1 and URA3, and to the wild-type level of URA2 mRNA in CSM.
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was increased on the URA2 open reading frame. Moreover,
this increased occupancy was only seen downstream of the
URA2 initiator region (Figure 7C). Similar results were ob-
tained in ChIP assays done in RPB3H3HA rpb1-L1397S cells,
showing that this effect is independent of the precipitating
antigen (Figure 7D). In contrast, two RNA polymerase II
alleles (rpb2-P1018S and rpb9D) with partial growth defects
similar to those of rpb1-L1397S signiﬁcantly reduced RNA
polymerase II signal, upstream and downstream of the in-
itiator region. Taken together, these data clearly show that
rpb1-L1397S activates URA2 by extending RNA polymerase II
occupancy downstream of the initiator region, thus recapitu-
lating the effect seen above for up2D or for wild-type and
ppr1D cells exposed to 6-azauracil.
rpb1-L1397S extends RNA polymerase II downstream
of IMD2, IMD3 and URA8
We have seen above that rpb1-L1397S generally reduced RNA
polymerase II occupancy, except for URA2. This was also
consistent with genome-wide transcriptome assays, showing
a moderate but signiﬁcant overexpression of URA2 in rpb1-
L1397S, compared with an isogenic wild-type control
(Figure 8A). Furthermore, these transcriptome and genome-
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Figure 6 Organisation of the Switch 1 loop in RNA polymerase II. (A) Sequence alignments with yeast, archaeal and bacterial subunits. The
Switch 1 loop domains (Gnatt et al, 2001) of Rpb1, Rpa190 and Rpc160 (S. cerevisiae) were aligned with the corresponding region of M.
jannaschii (subunit A) and of the b0 subunits of E. coli, Thermus aquaticus and Synechocystis 6803. Amino-acid conservation is shown in red
(all species), gold (Eukaryotes and Archaea) and blue (Prokaryotes only). Circles denote the mutated amino acids of rpb1-G1388V, rpb1-
L1397S, rpb1-S1401P and rpb1-F1402L.( B) Spatial organisation of the Bridge, Trigger and Switch 1 fold in S. cerevisiae, S. solfataricus and T.
thermophilus on the basis of PDB ﬁles 2NVZ, 2PMZ and 205I, respectively. These domains are shown on the Rpb1 sequence, with the same
colour code and with numbers indicating the corresponding amino-acid positions. (C) Organisation of the Switch 1 loop in RNA polymerase II,
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other genes, IMD2 (IMP dehydrogenase) and URA8 (CTP
synthase), which were both overexpressed and over-occupied
by RNA polymerase II in rpb1-L1397S. A few additional genes
were also overexpressed in the rpb1-L1397S transcriptome,
but with no higher RNA polymerase II occupancy of their
open reading frames (data not shown). Conversely, rpb1-
L1397S enhanced RNA polymerase II at ADE12 (adenylosu-
cinate synthase), but had no detectable effect on its mRNA
level.
Saccharomyces cerevisiae has two CTP synthases (URA7
and URA8) and three active IMP dehydrogenase genes
(IMD2, IMD3 and IMD4), with IMD1 as a pseudo-gene
inactivated by a frame-shift mutation in most laboratory
strains (Ozier-Kalogeropoulos et al, 1994; Nadkarni et al,
1995; Hyle et al, 2003). URA7 and URA8 are sufﬁciently
different to be distinguished by individual RT–PCR
assays, which clearly showed that rpb1-L1397S activated
only URA8 (Figure 8B). RT–PCR assays also conﬁrmed
the overexpression of the IMP dehydrogenase mRNA
in rpb1-L1397S but did not clearly distinguish between
IMD2, IMD3 and IMD4, due to their very similar
nucleotide sequences. However, our genome-wide ChIP
assays readily discriminated between these three genes.
This revealed that rpb1-L1397S strongly activated IMD2,
with some effect on IMD3 (Figure 8C) and no effect
at all on IMD4 (not shown). We considered the possibility
that the activation of CTP synthase and IMP dehydrogenase
genes may be an indirect effect of URA2 overexpression,
reﬂecting an increased cellular pool of UTP. However, the
activation of URA2 in up2D was not accompanied by a
parallel increase in URA8 or IMP dehydrogenase mRNA,
thus strongly arguing for a direct activating effect of
rpb1-L1397S (Figure 8B).
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Figure 7 RNA polymerase II occupancy in rpb1-L1397S.( A) RNA polymerase II occupancy at ADH1 and PYK1 in D535-4D (RPB3HHA) and
D535-9D (rpb1-L1397S RPB3HHA). Cells were grown in SDþaa at 301C. RNA polymerase II was immunoprecipitated with anti-HA antibodies.
A schematic map represents the oligonucleotide pairs used as primers. Position þ1 corresponds to the initiator ATG. (B) Genome-wide ChIP
assays. Three independent cultures of YGH2 (wild-type) and D711-13B (rpb1-L1397S) were grown in YPD at 301C. Chromatin was extracted
and analysed as described previously (Ghavi-Helm et al, 2008). (C) Distribution of RNA polymerase II at the URA2 locus. Data were extracted
from genome-wide analysis shown in Figure 7B above. The wild-type and rpb1-L1397S proﬁles are shown in grey and black, respectively.
(D) Effect of rpb1-L1397S, rpb2-P1018S and rpb9D on RNA polymerase II occupancy at URA2. Experimental conditions were as shown in
Figure 7A. The strains used were D535-4D (RPB3HHA), D535-9D (rpb1-L1397S RPB3HHA), YMW304-8C (rpb2-P1018S RPB3HHA) and
YWM305-2D (rpb9D RPB3HHA).
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initiation switch between short transcripts, synthesised from
an upstream initiator, and full-length mRNAs starting from a
downstream initiator (Escobar-Henriques et al, 2003;
Steinmetz et al, 2006; Kopcewicz et al, 2007; Jenks et al,
2008). RNA polymerase II is conﬁned to the upstream in-
itiator when wild-type cells are grown under repressing
conditions (Steinmetz et al, 2006), but extended to the entire
IMD2 gene in rpb1-L1397S or in derepressed wild-type cells
that have been exposed to mycophenolate (Figure 8C). In
URA8 and perhaps in ADE12, Thiebaut et al (2008) have
provided evidence for a transcriptional switch reminiscent of
the IMD2 case. Again, RNA polymerase II was mostly
restricted to the upstream part of the gene in wild-type cells
grown under repressing conditions, but extended to the entire
URA8 open reading frame in rpb1-L1397S (Figure 8C). A
similar effect may apply to ADE12, encoding the ﬁrst step
of the ATP biosynthetic pathway, where rpb1-L1397S moder-
ately increased RNA polymerase II occupancy downstream of
the promoter region (Figure 8D).
Discussion
Previous studies have shown that URA1 or URA3 are speci-
ﬁcally activated by Ppr1, a Zn activator of the Gal4-type
which responds to increased concentration of the orotate
and/or dihydro-orotate precursors of UTP (Loison et al,
1980; Losson and Lacroute, 1981; Flynn and Reece, 1999).
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Figure 8 Effect of rpb1-1397S on IMD2, IMD3, ADE12, URA7 and URA8.( A) Enrichment of RNA polymerase II transcripts in D535-9D (rpb1-
L1397S) compared with an isogenic wild-type obtained by complementation with pFL36-RPB1. The histogram represents median percentile
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transcripts are individualised by arrows. (B) RT–PCR of individual mRNAs. GR44-11C (WT), D711-13B (rpb1-L1397S) and FL51 (up2D) were
exponentially grown in SDþaa. Total RNA was extracted as described in Materials and methods. Individual mRNAs were quantiﬁed by
RT–PCR and expressed in arbitrary units, where 1.0 corresponds to the wild-type level. (C) RNA polymerase II occupancy at IMD2 and IMD3.
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the URA1 and URA3 promoters, lost in the ppr1D-null allele,
indicating a ‘classical’ mode of gene-speciﬁc activation on the
basis of a more effective recruitment of RNA polymerase II by
its pre-initiation complex. URA2, which encodes the main
rate-limiting enzyme of UTP biosynthesis, is activated when
UTP is depleted by 6-azauracil addition. However, the ppr1D-
null allele is fully competent for URA2 transcription.
Moreover, and in contrast to URA1 or URA3, URA2 activation
does not change the amount of RNA polymerase II residing at
or upstream of the URA2 initiator region, but operates instead
by extending RNA polymerase II occupancy to the URA2 open
reading frame.
Three cis-acting mutations constitutively expressing URA2
were selected in this study. They corresponded to very similar
deletions (up2D, up6D and up10D) removing a 55–70nt DNA
region upstream of the URA2 initiator. The up2D mutation
was studied in more detail. It extended RNA polymerase II to
the entire URA2 open reading frame, with no change in the
RNA polymerase II signal upstream of the URA2 initiator,
thus recapitulating the pattern seen in UTP-depleted wild-
type or ppr1D cells. Further studies (Thiebaut et al, 2008)
have shown that the corresponding DNA is transcribed from
an initiator region located some 100nt upstream of the main
URA2 mRNA 50-ends identiﬁed here, producing unstable
RNAs with the same transcriptional orientation as URA2,
which were no longer detected in up2D. Taken together, these
data suggest that URA2 may be regulated by an attenuation
mechanism related to the one recently described for IMD2
(Escobar-Henriques et al, 2003; Davis and Ares, 2006;
Steinmetz et al, 2006; Kopcewicz et al, 2007; Jenks et al,
2008).
A genome-wide selection for trans-acting mutations con-
stitutively expressing URA2 yielded three tightly clustered
rpb1 mutations (rpb1-L1397S, rpb1-S1401Pand rpb1-F1402L),
corresponding to the Rpb1a-47b helix of the Switch 1 loop.
rpb1-G1388V, which was initially selected for its ability to
alter transcription initiation in favour of downstream sites
(Berroteran et al, 1994) and belongs to the Rpb1-a47a helix,
also activates URA2 (see also Thiebaut et al, 2008). In
contrast, other partly defective RNA polymerase II mutations
failed to derepress URA2, indicating that URA2 activation is
by no means a general property of RNA polymerase II
mutants. Similar to up2D, rpb1-L1397S activates URA2 by
extending RNA polymerase II occupancy to the entire open
reading frame, with no change in the signal upstream of the
URA2 initiator, thereby reproducing the effect seen in up2D
and in UTP-depleted wild-type cells. Moreover, up2D and
rpb1-L1397S had epistatic effects on URA2 expression, indi-
cating that rpb1-L1397S is defective in the attenuation
mechanism lost in up2D itself. Finally, rpb1-L1397S and
wild-type URA2 mRNAs had similar 50-ends, as determined
by 50-RACE assays, and therefore use the same transcription
initiator.
The above-mentioned data indicate that changes in the
Switch 1 loop speciﬁcally activate URA2, despite their ad-
verse effects on growth and their reduced genome-wide RNA
polymerase II occupancy. Moreover, we were unable to
identify mutants encoding a speciﬁc regulator of URA2,
although it remained possible that such mutants are lethal
because they perturb some essential cellular process. The
Switch 1 loop forms an invariant R1386(a47a)-E1403(a47b)
dipole, holding the DNA template strand at positions þ2/þ3
downstream of the catalytic Mg
2þ (Gnatt et al, 2001). This
domain is highly conserved among eukaryotic and archaeal
RNA polymerases (Cramer et al, 2001; Hirata et al, 2008) and
a related structure exists in the bacterial enzyme, where it
also binds DNA at positions þ2/þ3 downstream of the
catalytic Mg
2þ (Vassylyev et al, 2007; Zaros et al, 2007).
The relation of this domain to the entry route of NTPs in
RNA polymerase II is unclear (Landick, 2005). One possibility
is that NTPs reach the catalytic site of RNA polymerase II by
its funnel-shaped pore (Cramer et al, 2001; Kettenberger et al,
2003; Westover et al, 2004; Landick, 2005), but it has also
been suggested that NTPs enter through the large DNA
channel, transiently binding the DNA template at nucleotides
þ2, þ3 and possibly þ4 (Gong et al, 2005), which implies
that NTPs pass by the Switch 1 loop before reaching the
catalytic Mg
2þ. Hence, the Switch 1 loop may act as an NTP-
sensing module, enabling RNA polymerase II to adopt a
processive mode of elongation when enough NTP is avail-
able. This would optimise the efﬁciency of transcription,
which may account for the cold- and heat-sensitive defects
of rpb1-L1397S, rpb1-S1401P and rpb1-F1402L and their in-
creased sensitivity to 6-azauracil and mycophenolate.
Strikingly, rpb1-L1397S also extended RNA polymerase II
occupancy downstream of the IMD2/IMD3 (IMP dehydrogen-
ase) and URA8 (CTP synthase) promoters, with some evi-
dence for a similar effect on ADE12 (adenylosuccinate
synthase). This makes biological sense, as the corresponding
genes encode rate-limiting enzymes in the de novo synthesis
of GTP, CTP and ATP. This suggests the rather non-canonical
view that nucleoside triphosphate shortage or RNA polymer-
ase II Switch 1 loop mutations (assumed here to mimic that
shortage) speciﬁcally activate the expression of genes that are
themselves critical for the de novo synthesis of NTPs. In other
words, the transcriptional response to NTP shortage would
not rely on dedicated activators or repressors (which have
been vainly searched for in the case of URA2 and IMD2) but
would be mediated by an NTP-sensing mechanism built in
the structure of RNA polymerase II itself.
In IMD2, there is good evidence that RNA polymerase II
molecules are recruited on a common pre-initiation complex,
followed by a start site switch leading to the alternative
production of upstream transcripts ended by Nab3/Nrd1-
dependent termination or full-length mRNAs transcribed
from a downstream initiator region. Start site selection is
presumably dictated by the nucleotide composition of the
surrounding DNA, with upstream transcription starting at Gs,
whereas IMD2 transcription starts in a G-poor DNA region
and is therefore favoured by low GTP pools (Escobar-
Henriques et al, 2003; Davis and Ares, 2006; Steinmetz
et al, 2006; Kopcewicz et al, 2007; Jenks et al, 2008). The
URA2 start choice, however, depends on a different mechan-
ism, as upstream initiation does not occur preferentially at
T’s and is not sensitive to the abundance of uracil (Thiebaut
et al, 2008). Conversely, we found that 3 out of 10 URA2
cDNAs produced under activating conditions started with a T,
which argues against the simple idea of a selection driven by
the nature of the starting nucleotide. Nevertheless, the up-
stream initiator is followed by an B60nt T-rich domain,
continued by 40nt that are conspicuously poor in T’s and
harbour the URA2 mRNA 50-ends. This pattern is conserved
among all Saccharomyces species sequenced to data (see
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provide some form of UTP-sensing. Further studies are
clearly needed to better understand how RNA polymerase II
responds to NTP shortage, and how this response is ulti-
mately converted into a speciﬁc control of the IMD2, URA2
and URA8 genes.
Materials and methods
Plasmids
Newly constructed plasmids are listed in Supplementary data.
Plasmids pFL35-II, pFL36-CII (CEN6 LEU2) and pFL39-CII (CEN6
TRP1), corresponding to pFL35, pFL36 and pFL39 (Bonneaud et al,
1991), with an extended polylinker of 90 nucleotides (Supplemen-
tary data). pFL80 and pFL82 are pURA2HLacZ pURA2 reporters
derived from pFL39-CII and pFL36-CII, respectively. They harbour a
KpnI–BamHI–NotI pURA2HLacZ cassette of 4392nt. The KpnI–
BamHI segment (1254nt) is formed by the TRK1–URA2 intergenic
region, preceded by GGTACCAGCACAACGCTCTAA (the KpnI site is
in italics) and followed by ATGGATCC (BamHI). It is cloned in-frame
to the initiator ATG of a BamHI–NotI LacZ cassette. pFL83 is pFL80
where the LacZ open reading frame has been replaced by a BamHI–
NotI HIS3 (S. cerevisiae) cassette. As pFL80 poorly complemented
trp1 mutant strains, which overexpressed the pURA2 promoter (due
to some transcriptional interference between LacZ and TRP1), we
also used pFL80-H2, a pURA2HLacZ reporter with a lower LacZ
expression. This plasmid was selected after random insertion of
genomic HindIII fragments in the unique HindIII site downstream of
LacZ (Supplementary data). The HindIII fragment of pFL80-H2
corresponded to positions 7679–8251 of the TEL1 gene and was
inserted in a transcriptional orientation opposite to the one of TRP1.
Plasmids pFL80-KB, pFL80-BS and pFL80-CS correspond to
KpnI/BsrGI, BsrGI/SalI and ClaI/SalI deletions of pFL80, respec-
tively. pFL80-INTD was precisely deleted of the DNA comprised
between nucleotides  384 to  63, where 1 corresponds to the
URA2 start codon. The pFL83-upD2, -up6D and -up10D plasmids
were obtained by error-prone ampliﬁcation of the KpnI–BamHI
cassette of pFL83, which was recombined into the original vector by
co-transformation with linearised pFL83 DNA deleted of its BsrGI–
SalI fragment. Mutant plasmids were selected on 3-aminotriazol in
the presence of uracil, ampliﬁed in Escherichia coli, retransformed
and veriﬁed for their overexpression. The corresponding upD alleles
were transferred to pFL80 by KpnI–BamHI subcloning.
Yeast strains
Yeast mutants are listed as Supplementary data. Plasmid shufﬂe
assays were done in the presence of 5-ﬂuoro-orotic acid to counter-
select URA3 plasmids (Boeke et al, 1984). Except when stated
otherwise, they were constructed in BMA64-1A and BMA64-URA3, a
URA3
þ revertant of BMA64-1A (Baudin-Baillieu et al, 1997). Yeasts
were grown on SDþaa, corresponding to the standard synthetic
dextrose medium supplemented with histidine, tryptophan and
adenine sulphate (20mg/l), leucine and lysine (30mg/l). In
b-galactosidase assays, SDþaa was replaced by the complete synthetic
medium CSM (manufactured by BIO101) supplemented with a
complete set of amino acids but lacking uracil. CSM supplemented
with 2g/l of uracil (CSMþU) fully represses URA2, whereas adding
6-azauracil at 20mg/l (CSMþ 6AU) fully activates URA2.
FL50 was obtained by inserting the integrative plasmid pFL81
(TRP1 pURA2HHIS3) at the EcoRV site of the trp1-1 allele in W303-
1B. When grown in the presence of uracil, this strain has an
increased sensitivity to 3-aminotriazol, due to the repression of its
pURA2HHIS3 reporter. FL52 is FL50 transformed with pFL82 (LEU2
pURA2HLacZ). FL-M9, M10, M13 and M23 are FL52 mutants
selected from UV-irradiated cells (about 1% survival) plated for 3
days at about 4 10
6 cells on leucine omission plates with uracil
(2g/l) and 50 or 100mM of 3-aminotriazol. b-galactosidase was
assayed in a loop of cells put on Whatman paper soaked in 2ml of Z
buffer (Miller, 1972) containing X-Gal (1g/l) and a drop of
zymolase. Dark blue clones were tested again, using freshly grown
cells suspended in 0.6ml of Z buffer and vortexed for 1min with an
equal volume of glass beads. Cells were refrigerated in an ice bath,
treated with a second round of glass bead extraction, pelleted by
centrifugation at 14000r.p.m. and tested for b-galactosidase after
10min at 371C. Mutant strains with an at least ﬁvefold increase in
b-galactosidase were retained for further analysis. A ﬁfth mutant
was a fur1 allele partly defective for UMP pyrophosphorylase,
impairing the metabolic conversion of uracil into UMP.
FL51, with the up2D allele integrated on the chromosome by
homologous recombination, was constructed by subcloning the
KpnI–BamHI fragment of pFL81-up2D into pFL35-II. The resulting
plasmid was linearised at the BsmI site of the pURA2 promoter
region, to direct its integration by homologous recombination with
the pURA2 region of BMA64-URA3. The corresponding transfor-
mants harboured the TRP1 cassette ﬂanked by wild-type and up2D
tandem copies of pURA2. Tryptophan auxotrophic clones sponta-
neously occurred by recombination between these pURA2 copies
and were selected by nystatin enrichment (Snow, 1966), yielding
single copies of pURA2. Among them, up2D mutants were identiﬁed
by their weak resistance to 5-ﬂuorouracil (10
 5M), and were further
checked by PCR ampliﬁcation.
ChIP and genome-wide ChIP-chip assays
Chromatin immunoprecipitation assays were as described else-
where (Ghavi-Helm et al, 2008). All experiments were performed
on three independent cultures of 100ml, harvested at an OD600 of
0.3–0.5. Cells were grown in SDþaa with or without uracil, or UTP-
depleted by adding 200mg/l of 6-azauracil to log-phase cells grown
in SDþaa and grown for three additional doubling times. RNA
polymerase II was immunoprecipitated with Dynabeads anti-mouse
IgG (Dynal Biotech), using anti-CTD antibodies (8WG16), or anti-
hemagglutinin A antibodies (12CA5) in the case of Rpb3-HA tagged
strains. Sua7-TAP and Rad3-TAP proteins were directly immuno-
precipitated on Dynabeads anti-mouse IgG. Phosphorylated
variants of the RNA polymerase CTD domain were immunopreci-
pitated with Dynabeads anti-mouse IgM, using anti-Ser2
P (H5,
Covance) and anti-Ser5
P (H14, Covance) antibodies. ChIP signals
were calculated by the immunoprecipitation/input signal. The
value 1.0 was arbitrarily given to the reference signal provided by
amplifying the GAL1 gene. Genome-wide ChIP assays, on the basis
of three independent cultures in YPD or CSM medium for
mycophenolate experiments (10mg/l) medium, were described
elsewhere (Harismendy et al, 2003) and were based on DNA arrays
with over 40000 oligonucleotide probes covering 12Mb of the yeast
genome (Ghavi-Helm et al, 2008).
RNA and transcriptome assays
Total RNA was extracted from three independent, exponential
cultures with hot phenol and reverse-transcribed using 1mg of total
RNA, Super-Script II reverse transcriptase (Invitrogen) and random
hexamers as primers. Controls without reverse transcriptase
showed negligible levels of DNA contamination. DNA was
quantiﬁed by real-time PCR ampliﬁcation (Applied Biosytems,
System SDS Software) using primers listed in Supplementary data.
mRNA levels are calculated as a ratio of measured mRNA and ACT1
mRNA. The 50-ends of URA2 mRNAs were mapped by sequencing
cDNAs obtained by the RNA ligase mediated-RACE technique
(using an RLM-RACE kit from Ambion), according to the protocol
provided by the manufacturer. Yeast micro-arrays were probed
against total RNA extracted from three independent cultures of
strains BMA64-URA3 (wild type) and FL-M9 (rpb1-L1397S)g r o w no n
SDþaa at 301C, to an OD600 of 0.55. cDNA synthesis, puriﬁcation,
indirect labelling, microarray hybridisation, scanning and analysis
were done according to standard protocols (Soutourina et al, 2006),
with two independent hybridisations for each RNA batch.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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